isoniazid has been researched along with pyrimethamine in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.56) | 29.6817 |
2010's | 16 (88.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Ali, MA; Choon, TS; Ismail, R; Kumar, RS; Wei, AC; Yoon, YK | 1 |
Danac, R; Mangalagiu, II | 1 |
Asís, SE; Buldain, GY; Muscia, GC | 1 |
Ali, MA; Choon, TS; Kanchithalaivan, S; Ponnuchamy, S; Ranjith Kumar, R | 1 |
Ashraf Ali, M; Choon, TS; Devi Bala, B; Muthusaravanan, S; Perumal, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
Ashraf Ali, M; Bharkavi, C; Muthusubramanian, S; Osman, H; Perumal, S; Vivek Kumar, S | 2 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Baikova, IP; Giniyatullina, GV; Kataev, VE; Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE | 1 |
Bera, S; Mondal, D | 1 |
Bandarizadeh, B; Dutz, W; Fakouhi, T; Jennings-Khodadad, E; Kohout, E; Post, C | 1 |
2 review(s) available for isoniazid and pyrimethamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
16 other study(ies) available for isoniazid and pyrimethamine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cycloaddition Reaction; High-Throughput Screening Assays; Microbial Sensitivity Tests; Pyrrolidines | 2013 |
Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III.
Topics: Antitubercular Agents; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen; Pyridines | 2014 |
Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
Topics: Acridines; Animals; Antitubercular Agents; Cell Line; Cyclization; Drug Design; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines | 2014 |
Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidinediones | 2014 |
Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
Topics: Antitubercular Agents; Benzopyrans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthoquinones; Triazoles | 2014 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
Topics: Acetylcholinesterase; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholinesterase Inhibitors; Chromones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indenes; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
One-pot microwave assisted stereoselective synthesis of novel dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and evaluation of their antimycobacterial activity and inhibition of AChE.
Topics: Acetylcholinesterase; Antitubercular Agents; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microwaves; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2017 |
Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
Topics: Antitubercular Agents; Azepines; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triterpenes | 2018 |
Therapy and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Amidines; Aminosalicylic Acid; Animals; Complement Fixation Tests; Drug Therapy, Combination; Humans; Immunoglobulin G; Infant; Isoniazid; Pentamidine; Pneumonia, Pneumocystis; Protein-Energy Malnutrition; Pyrimethamine; Rabbits; Rats; Sulfadoxine; Sulfanilamides | 1976 |